Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV^POS Cancers.

In contrast, we did not observe highly significant differences in the rate of tumor growth in CD4 + -T cell- or NK-cell-depleted mice compared to non-depleted mice, suggesting that these cell subtypes do not mediate the antitumor effects observed.

also in 132,142 other papers